Pulse Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.3% | -16.9% | -17.8% | +130.2% | +42.4% | +0.7% | -9.8% | -9.6% | -11.6% | -15.1% | +41.6% | |
| – | -12.2% | -20.9% | -24.0% | +195.2% | +48.5% | +1.2% | -10.5% | -10.2% | -14.1% | -14.7% | +48.6% | |
| – | -11.9% | -21.4% | -24.9% | +201.7% | +49.4% | +1.1% | -10.8% | -10.5% | -15.2% | -15.4% | +48.7% | |
| – | -11.9% | -21.4% | -24.9% | +201.7% | +49.4% | +1.1% | -10.8% | -10.5% | -15.2% | -15.4% | +48.7% | |
| – | – | – | – | – | – | – | – | – | +1,726.7% | -42.7% | -22.3% | |
| – | – | – | – | – | – | – | +70.0% | +11.8% | +138.6% | +51.5% | +14.6% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -8.1% | -8.9% | -9.7% | -10.8% | -12.0% | -13.6% | -13.9% | -18.3% | -22.4% | -29.0% | -45.6% | |
| – | +7.2% | -13.0% | +4.5% | +3.4% | +26.5% | -15.2% | +5.6% | +1.9% | -3.8% | -0.9% | +4.8% | |
| – | +23.5% | -24.3% | +17.3% | +13.1% | +49.2% | -22.8% | +15.7% | +8.0% | -18.3% | +23.6% | +12.1% | |
| – | +4.1% | +4.1% | +4.1% | +4.1% | +13.6% | +3.8% | +3.8% | +4.1% | +3.4% | +3.6% | +3.6% | |
| – | +30.0% | -6.8% | -4.4% | +5.5% | -3.1% | +41.7% | +15.7% | +8.6% | -6.7% | -0.6% | +2.6% | |
| – | -14.9% | -18.2% | -25.7% | +193.4% | +45.2% | +3.1% | -11.8% | -11.3% | -13.0% | -17.8% | +50.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.2% | +3.6% | +6.8% | -4.4% | +14.9% | +0.2% | +0.2% | +0.0% | +0.6% | +2.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.